Clinical trial
Escitalopram for Agitation in Alzheimer's Disease
NCT03108846 is registered in ClinicalTrials.gov with JHSPH Center for Clinical Trials as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Escitalopram for Agitation in Alzheimer's Disease
- Lead sponsor
- JHSPH Center for Clinical Trials
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- January 3, 2018
- Completion date
- May 31, 2025
- Enrollment
- 187 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.